Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Alfimeprase

EU orphan designation number: EU/3/05/322
Active ingredient: Alfimeprase
Indication: Treatment of acute peripheral arterial occlusion
Sponsor: Quadramed Limited
MG House Rumbolds Hill, Midhurst, West Sussex GU29 9BY, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
07/11/2005 Centralised Orphan - Designation EMEA/OD/060/05 (2005)4359 of 28/10/2005
03/07/2006 Centralised Orphan - Transfer of orphan designation EMEA/OD/060/05/T/01 (2006)3093 of 29/06/2006
20/09/2007 Centralised Orphan - Transfer of orphan designation EMEA/OD/060/05/T/02 (2007)4370 of 17/09/2007
02/07/2008 Centralised Orphan - Removal of orphan designation from Community Register